Analyst Consensus ?
ConsensusHold46 ratings
Bullish2350.0%
Neutral2247.8%
Bearish12.2%
The PNC Financial Services Group, Inc. · PNC · FY2026 Q3 · Calendar Q4 2026
PNC Raises Full-Year Outlook as Loan and Fee Growth Accelerate
PNC's Q3 results support a constructive operating picture: expansion markets, the FirstBank acquisition, asset repricing, and capital-markets activity are supporting growth, while management raised its full-year outlook. The counterweight is that deposit costs and a lower-spread loan mix are compressing NIM, so sustained earnings momentum depends on growth translating into revenue without worsening funding and credit pressures.
Reported Before market openNYSEFinancial Services
$86.09B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $4.91
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $6.61B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+0.3%
Event window
SPY move
+0.2%
Same window
Abnormal move
+0.1%
Stock minus SPY
Volume
1.1×
Versus trailing sessions
Subsequent drift
0.0%
Up to 20 sessions
PNCSPY benchmark
Ask FN2 about PNC FY2026 Q3
Transcript, numbers and history already loaded
What drove PNC's +0.3% move after FY2026 Q3 earnings?What changed in PNC's guidance and outlook in FY2026 Q3?Give me the bull and bear case for PNC after FY2026 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter's maintained outlook, management raised full-year guidance and provided a clearer path for fixed-rate asset repricing to support net interest income into 2027. The call also added detail on the AI and agentic technology roadmap and noted completion of the student-loan business exit with de minimis financial impact.
Guidance delta
Management raised full-year guidance to approximately 13.5% loan growth, 15.5% net interest income growth, and 13.7% total revenue growth.
Key takeaways
- Q3 net income was $2.1 billion, adjusted EPS was $5.09, and ROE exceeded 18%.
- Loan growth was driven by expansion markets and the FirstBank acquisition, which added $15 billion of loans.
- Deposits increased 1% year over year, while lower-spread loan mix and higher deposit costs compressed NIM.
- Capital-markets fees were up 40% year to date, with management expecting another 15% increase in Q4.
Management priorities
- Expand branches and new client relationships in growth markets.
- Continue the mobile-app and Total Rewards rollout.
- Use fixed-rate asset repricing to support net interest income through 2027.
- Advance AI and agentic technology infrastructure while pursuing the $350 million 2026 cost-reduction target.
Follow PNC with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$214.94Current
$162Low
$238.19Average
$305High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 15, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Buy | Buy | Maintain | Oct 5, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Oct 5, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 2, 2026 |
| Truist Securities | Hold | Hold | Maintain | Oct 1, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Oct 1, 2026 |
| HSBC | Buy | Buy | Maintain | Sep 28, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 20, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 16, 2026 |
| Stephens & Co. | Overweight | Overweight | Maintain | Jul 16, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 16, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 16, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 16, 2026 |
| Baird | Outperform | Outperform | Maintain | Jul 16, 2026 |
| Argus Research | Buy | Buy | Maintain | Jul 16, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 29, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Apr 16, 2026 |
| B of A Securities | Buy | Buy | Maintain | Apr 16, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jan 20, 2026 |
| Keefe, Bruyette& Woods | Market Perform | Market Perform | Maintain | Dec 17, 2025 |
| Piper Sandler | Overweight | Neutral | Upgrade | Oct 9, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Sep 19, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jul 3, 2025 |
| Compass Point | Neutral | Neutral | Maintain | Dec 10, 2024 |
| Jefferies | Hold | Hold | Maintain | Jul 3, 2024 |
| Odeon Capital | Buy | Hold | Upgrade | Dec 14, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Jul 19, 2023 |
| Deutsche Bank | Buy | Hold | Upgrade | Jan 6, 2023 |
| Nomura | Buy | Neutral | Upgrade | Apr 16, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Jan 10, 2019 |
| Macquarie | Neutral | Outperform | Downgrade | Nov 27, 2018 |
| BMO Capital | Market Perform | Outperform | Downgrade | Nov 19, 2018 |
| Bernstein | Outperform | Market Perform | Upgrade | Oct 15, 2018 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| Keefe Bruyette & Woods | Market Perform | Outperform | Downgrade | Nov 29, 2016 |
| CLSA | Underperform | Underperform | Maintain | Sep 23, 2016 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Mar 14, 2016 |
| Sterne Agee | Neutral | Buy | Downgrade | Oct 27, 2014 |
| Rafferty Capital | Hold | Buy | Downgrade | Apr 17, 2014 |
| Rafferty | Hold | Buy | Downgrade | Apr 17, 2014 |
| Sandler O'Neill | Buy | Hold | Upgrade | Jan 16, 2014 |
| Evercore Partners | Equal Weight | Overweight | Downgrade | Dec 16, 2013 |
| SunTrust Robinson Humphrey | Neutral | Buy | Downgrade | Feb 6, 2013 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Oct 17, 2012 |
| Stifel | Hold | Buy | Downgrade | Oct 17, 2012 |
| ISI Group | Hold | Buy | Downgrade | Oct 16, 2012 |
| Bank oferica | Buy | Buy | Maintain | Apr 19, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $214.94. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Goldman Sachs | Analyst unavailable | $250 | $221.03 | +16.3% | Oct 5, 2026 |
| UBS | Analyst unavailable | $286 | $221.03 | +33.1% | Oct 5, 2026 |
| Truist Financial | John McDonald | $252 | $216.4 | +17.2% | Oct 1, 2026 |
| Evercore ISI | John Pancari | $265 | $222.26 | +23.3% | Oct 1, 2026 |
| HSBC | Domenico Santoro | $283 | $224.42 | +31.7% | Sep 28, 2026 |
| Deutsche Bank | Analyst unavailable | $265 | $252.51 | +23.3% | Jul 23, 2026 |
| Argus Research | Analyst unavailable | $280 | $254.57 | +30.3% | Jul 16, 2026 |
| Oppenheimer | Analyst unavailable | $281 | $253.41 | +30.7% | Jul 16, 2026 |
| RBC Capital | Analyst unavailable | $273 | $254.15 | +27.0% | Jul 16, 2026 |
| Stephens | Analyst unavailable | $275 | $254.15 | +27.9% | Jul 16, 2026 |
| Robert W. Baird | Analyst unavailable | $280 | $254.15 | +30.3% | Jul 16, 2026 |
| Barclays | Jason Goldberg | $284 | $254.15 | +32.1% | Jul 16, 2026 |
| Wells Fargo | Analyst unavailable | $285 | $254.15 | +32.6% | Jul 16, 2026 |
| Goldman Sachs | Richard Ramsden | $280 | $254.15 | +30.3% | Jul 15, 2026 |
| Jefferies | David Chiaverini | $305 | $254.15 | +41.9% | Jul 15, 2026 |
| UBS | Analyst unavailable | $288 | $255.06 | +34.0% | Jul 7, 2026 |
| Evercore ISI | John Pancari | $280 | $251.69 | +30.3% | Jul 6, 2026 |
| Wells Fargo | Analyst unavailable | $270 | $249.49 | +25.6% | Jul 6, 2026 |
| Oppenheimer | Analyst unavailable | $271 | $246.13 | +26.1% | Jun 30, 2026 |
| Morgan Stanley | Manan Gosalia | $278 | $246.06 | +29.3% | Jun 29, 2026 |
| Truist Financial | Analyst unavailable | $257 | $243.7 | +19.6% | Jun 26, 2026 |
| Truist Financial | Analyst unavailable | $245 | $222.71 | +14.0% | Apr 16, 2026 |
| Oppenheimer | Analyst unavailable | $268 | $222.96 | +24.7% | Apr 16, 2026 |
| Morgan Stanley | Manan Gosalia | $267 | $223.17 | +24.2% | Apr 16, 2026 |
| Barclays | Analyst unavailable | $277 | $222.06 | +28.9% | Apr 16, 2026 |
| Truist Financial | John McDonald | $234 | $205.46 | +8.9% | Mar 26, 2026 |
| UBS | Analyst unavailable | $263 | $238.86 | +22.4% | Feb 4, 2026 |
| Oppenheimer | Analyst unavailable | $284 | $221.38 | +32.1% | Jan 20, 2026 |
| Evercore ISI | Analyst unavailable | $260 | $221.38 | +21.0% | Jan 20, 2026 |
| Morgan Stanley | Analyst unavailable | $221 | $221.09 | +2.8% | Jan 20, 2026 |
| Truist Financial | John McDonald | $240 | $223.18 | +11.7% | Jan 20, 2026 |
| RBC Capital | Analyst unavailable | $235 | $223.18 | +9.3% | Jan 20, 2026 |
| HSBC | Saul Martinez | $206 | $215.99 | -4.2% | Jan 7, 2026 |
| Evercore ISI | John Pancari | $247 | $216.97 | +14.9% | Jan 6, 2026 |
| Barclays | Jason Goldberg | $271 | $211.46 | +26.1% | Jan 5, 2026 |
| Morgan Stanley | Betsy Graseck | $211 | $209.86 | -1.8% | Dec 18, 2025 |
| Truist Financial | Analyst unavailable | $229 | $212.66 | +6.5% | Dec 18, 2025 |
| Piper Sandler | Analyst unavailable | $220 | $190.16 | +2.4% | Oct 9, 2025 |
| UBS | Analyst unavailable | $229 | $194.43 | +6.5% | Oct 7, 2025 |
| Evercore ISI | Analyst unavailable | $230 | $201.85 | +7.0% | Sep 30, 2025 |
| Morgan Stanley | Analyst unavailable | $206 | $203.32 | -4.2% | Sep 29, 2025 |
| Truist Financial | John McDonald | $210 | $205.1 | -2.3% | Sep 24, 2025 |
| Raymond James | Analyst unavailable | $225 | $206.27 | +4.7% | Sep 19, 2025 |
| Piper Sandler | Analyst unavailable | $211 | $201.89 | -1.8% | Sep 10, 2025 |
| Truist Financial | John McDonald | $201 | $203.77 | -6.5% | Sep 8, 2025 |
| Oppenheimer | Analyst unavailable | $238 | $192.55 | +10.7% | Jul 30, 2025 |
| Goldman Sachs | Richard Ramsden | $190 | $189.93 | -11.6% | Oct 16, 2024 |
| Wells Fargo | Mike Mayo | $215 | $192.34 | +0.0% | Oct 16, 2024 |
| Barclays | Jason Goldberg | $229 | $192.34 | +6.5% | Oct 16, 2024 |
| Evercore ISI | John Pancari | $225 | $192.34 | +4.7% | Oct 15, 2024 |
| Stephens | Terry McEvoy | $200 | $192.34 | -7.0% | Oct 15, 2024 |
| Goldman Sachs | Richard Ramsden | $180 | $178.78 | -16.3% | Sep 10, 2024 |
| Piper Sandler | Scott Siefers | $178 | $184.29 | -17.2% | Sep 3, 2024 |
| Bank of America Securities | Ebrahim Poonawala | $200 | $172.17 | -7.0% | Aug 15, 2024 |
| Goldman Sachs | Richard Ramsden | $182 | $179.71 | -15.3% | Jul 17, 2024 |
| UBS | Erika Najarian | $179 | $156.51 | -16.7% | Jul 8, 2024 |
| Wells Fargo | Mike Mayo | $194 | $150.25 | -9.7% | Jun 12, 2024 |
| Piper Sandler | Scott Siefers | $158 | $153.1 | -26.5% | May 24, 2024 |
| Jefferies | Ken Usdin | $162 | $146.67 | -24.6% | Apr 17, 2024 |
| Evercore ISI | John Pancari | $175 | $146.54 | -18.6% | Apr 17, 2024 |
| Jefferies | Ken Usdin | $171 | $157.37 | -20.4% | Apr 8, 2024 |
| HSBC | Saul Martinez | $155 | $159.97 | -27.9% | Mar 28, 2024 |
| UBS | Analyst unavailable | $176 | $164.3 | -18.1% | Jan 10, 2023 |
| Deutsche Bank | Analyst unavailable | $190 | $159.37 | -11.6% | Jan 6, 2023 |
| Barclays | Analyst unavailable | $218 | $160.42 | +1.4% | Jan 3, 2023 |
| Morgan Stanley | Analyst unavailable | $178 | $149.14 | -17.2% | Dec 19, 2022 |
| Morgan Stanley | Analyst unavailable | $177 | $148.81 | -17.7% | Dec 16, 2022 |
| Morgan Stanley | Analyst unavailable | $176 | $150.66 | -18.1% | Dec 6, 2022 |
| Deutsche Bank | Analyst unavailable | $200 | $166.64 | -7.0% | Sep 12, 2022 |
| Credit Suisse | Analyst unavailable | $170 | $156.46 | -20.9% | Jul 18, 2022 |
| Barclays | Analyst unavailable | $222 | $153.42 | +3.3% | Jul 18, 2022 |
| Morgan Stanley | Analyst unavailable | $180 | $153.42 | -16.3% | Jul 18, 2022 |
| Morgan Stanley | Analyst unavailable | $168 | $158.38 | -21.8% | Jul 12, 2022 |
| Wells Fargo | Analyst unavailable | $202 | $157.77 | -6.0% | Jul 1, 2022 |
| Wolfe Research | Analyst unavailable | $177 | $167.63 | -17.7% | May 26, 2022 |
| Raymond James | Michael Rose | $210 | $178.05 | -2.3% | Apr 20, 2022 |
| Argus Research | Stephen Biggar | $220 | $175.75 | +2.4% | Apr 18, 2022 |
| Argus Research | Stephen Biggar | $245 | $200.96 | +14.0% | Jan 22, 2022 |
| Evercore ISI | John Pancari | $235 | $208.52 | +9.3% | Jan 19, 2022 |
| UBS | Erika Najarian | $245 | $208.52 | +14.0% | Jan 19, 2022 |
| Barclays | Jason Goldberg | $250 | $207.07 | +16.3% | Jan 3, 2022 |
| Citigroup | Keith Horowitz | $220 | $200.68 | +2.4% | Dec 16, 2021 |
| Wells Fargo | Mike Mayo | $240 | $215.36 | +11.7% | Oct 25, 2021 |
| Bank of America Securities | Ebrahim Poonawala | $215 | $198.03 | +0.0% | Oct 15, 2021 |
| KBW | David Konrad | $193 | $184.53 | -10.2% | Jul 6, 2021 |
| Compass Point | Dave Rochester | $190 | $190.37 | -11.6% | May 18, 2021 |
| Stephens | Terry McEvoy | $195 | $174.48 | -9.3% | Apr 19, 2021 |
Track every rating change on PNC the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationPNC Financial Services Group, Inc. stands as a diversified financial institution operating across the United States. Founded in 1852 and headquartered in Pittsburgh, Pennsylvania, the company maintains an extensive physical footprint, boasting 2,591 branches and 9,502 ATMs. Its Retail Banking division delivers a full spectrum of financial solutions to individual consumers and small businesses. This includes a variety of deposit accounts such as checking, savings, money market, and certificates of deposit. Lending products span residential mortgages, home equity loans and lines of credit, auto loans, credit cards, education financing, and personal and small business loans and credit lines. Additionally, the segment provides brokerage, insurance, investment, and cash management services, all accessible via its branch network, ATMs, call centers, and digital banking channels. The Corporate & Institutional Banking segment caters to the needs of mid-sized and large corporations, government entities, and not-for-profit organizations.…
Historical context
All PNC earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| USB-PR U.S. Bancorp | FY2026 Q3 · Calendar Q4 2026 | — | — | U.S. Bancorp raises outlook as BTIG and fee growth lift Q3 |
| USB-PS U.S. Bancorp Depositary Shares, | FY2026 Q3 · Calendar Q4 2026 | — | — | U.S. Bancorp raises guidance as BTIG and fee growth support Q3 |
| FHN First Horizon Corporation | FY2026 Q3 · Calendar Q4 2026 | — | +2.1% | First Horizon Repositions Assets to Support NIM and Growth |
| USB-PQ U.S. Bancorp | FY2026 Q3 · Calendar Q4 2026 | — | — | U.S. Bancorp raises guidance as fees and BTIG support growth |
| USB-PA U.S. Bancorp PERP PFD SER A | FY2026 Q3 · Calendar Q4 2026 | — | — | U.S. Bancorp raises 2026 outlook as BTIG and payments gain traction |
| USB U.S. Bancorp | FY2026 Q3 · Calendar Q4 2026 | — | +2.2% | U.S. Bancorp pairs record revenue with a broader growth agenda |
Latest beats and misses
Who reports nextBeat on EPS
Get the PNC recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-15T18:08:00.211638+00:00
- FN2 earnings calendar · 2026-10-15T01:23:12.167262+00:00
- Polygon adjusted daily market bars · 2026-10-15T18:10:44.880988+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-15T18:10:44.878358+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-15. For educational purposes only; not investment advice.